Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?

DOI: 10.1177/1758835919861905

Keywords: immunotherapy, PD-1, PD-L1, renal cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text